114 related articles for article (PubMed ID: 8620464)
1. Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone.
Hytrek SD; McLaughlin PJ; Lang CM; Zagon IS
Cancer Lett; 1996 Mar; 101(2):159-64. PubMed ID: 8620464
[TBL] [Abstract][Full Text] [Related]
2. Gene-peptide relationships in the developing rat brain: the response of preproenkephalin mRNA and [Met5]-enkephalin to acute opioid antagonist (naltrexone) exposure.
Zagon IS; McLaughlin PJ
Brain Res Mol Brain Res; 1995 Oct; 33(1):111-20. PubMed ID: 8774952
[TBL] [Abstract][Full Text] [Related]
3. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
Zagon IS; McLaughlin PJ
Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems.
McLaughlin PJ; Zagon IS
Life Sci; 1987 Sep; 41(12):1465-72. PubMed ID: 3041143
[TBL] [Abstract][Full Text] [Related]
5. Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.
Zagon IS; McLaughlin PJ
Brain Res; 1989 Feb; 480(1-2):16-28. PubMed ID: 2540873
[TBL] [Abstract][Full Text] [Related]
6. Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.
Zagon IS; Hytrek SD; Smith JP; McLaughlin PJ
Cancer Lett; 1997 Jan; 112(2):167-75. PubMed ID: 9066724
[TBL] [Abstract][Full Text] [Related]
7. Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.
Donahue RN; McLaughlin PJ; Zagon IS
Exp Biol Med (Maywood); 2011 Sep; 236(9):1036-50. PubMed ID: 21807817
[TBL] [Abstract][Full Text] [Related]
8. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.
Zagon IS; Hytrek SD; McLaughlin PJ
Am J Physiol; 1996 Sep; 271(3 Pt 2):R511-8. PubMed ID: 8853370
[TBL] [Abstract][Full Text] [Related]
9. Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats.
Parkes H; Sinclair JD
Alcohol; 2000 Jul; 21(3):215-21. PubMed ID: 11091024
[TBL] [Abstract][Full Text] [Related]
10. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
Lee SC; Yoburn BC
Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
[TBL] [Abstract][Full Text] [Related]
11. Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.
Zagon IS; Hytrek SD; Lang CM; Smith JP; McGarrity TJ; Wu Y; McLaughlin PJ
Am J Physiol; 1996 Sep; 271(3 Pt 2):R780-6. PubMed ID: 8853403
[TBL] [Abstract][Full Text] [Related]
12. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.
Zagon IS; Wu Y; McLaughlin PJ
J Invest Dermatol; 1996 Mar; 106(3):490-7. PubMed ID: 8648182
[TBL] [Abstract][Full Text] [Related]
13. The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin.
Wilson RP; McLaughlin PJ; Lang CM; Zagon IS
Cell Prolif; 2000 Apr; 33(2):63-73. PubMed ID: 10845251
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.
Immonen JA; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2014 Oct; 239(10):1300-9. PubMed ID: 25030485
[TBL] [Abstract][Full Text] [Related]
15. Opioids and differentiation in human cancer cells.
Zagon IS; McLaughlin PJ
Neuropeptides; 2005 Oct; 39(5):495-505. PubMed ID: 16169076
[TBL] [Abstract][Full Text] [Related]
16. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors.
Zagon IS; Sassani JW; McLaughlin PJ
Brain Res; 1998 Jul; 798(1-2):254-60. PubMed ID: 9666142
[TBL] [Abstract][Full Text] [Related]
17. Opioid growth factor regulates the cell cycle of human neoplasias.
Zagon IS; Roesener CD; Verderame MF; Ohlsson-Wilhelm BM; Levin RJ; McLaughlin PJ
Int J Oncol; 2000 Nov; 17(5):1053-61. PubMed ID: 11029512
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of chronic treatment with [MET5]-enkephalin on hematological values and natural killer cell activity in athymic mice.
Zalys R; Zagon IS; Bonneau RH; Lang CM; McLaughlin PJ
Life Sci; 2000 Jan; 66(9):829-34. PubMed ID: 10698357
[TBL] [Abstract][Full Text] [Related]
19. Chronic opioid antagonist treatment selectively regulates trafficking and signaling proteins in mouse spinal cord.
Patel CN; Rajashekara V; Patel K; Purohit V; Yoburn BC
Synapse; 2003 Oct; 50(1):67-76. PubMed ID: 12872295
[TBL] [Abstract][Full Text] [Related]
20. Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors.
Zagon IS; Tobias SW; Hytrek SD; McLaughlin PJ
Pharmacol Biochem Behav; 1998 Jan; 59(1):201-7. PubMed ID: 9443556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
